Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Stedman

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Cardiovascular Endocrinology & Metabolism|September 25, 2024
The lifetime healthcare costs of female obesity: modeling of England data and the costs of current pharmacotherapyAdrian H Heald, Mike Stedman, John Warner-Levy, et al.
Lancet (London, England)|January 22, 2019
The costs of drug prescriptions for diabetes in the NHSMike Stedman, Mark Lunt, Mark Livingston, et al.
Primary Care Diabetes|July 16, 2025
The Influence of Local Service Configuration on All-Cause Mortality: An Age- and Sex-Standardised AnalysisMike Stedman, Mark Davies, Adam Robinson, et al.
Cardiovascular Endocrinology & Metabolism|June 26, 2023
First episode psychosis and weight gain a longitudinal perspective in Cheshire UK: a comparison between individuals with nonaffective versus affective psychosisAdrian H Heald, Mike Stedman, Chris Daly, et al.
The Journal of Clinical Endocrinology and Metabolism|August 12, 2025
Risk of death and adverse effects in patients on Liothyronine: a multi-source systematic review and meta-analysisSuhani Bahl, Peter N Taylor, Lakdasa D Premawardhana, et al.
Journal of Pharmaceutical Policy and Practice|December 21, 2023
Changes in prescribing of psychotropic vs some physical health medication in primary care through the COVID-19 pandemic in England: a national-level surveyUnaiza Waheed, Mike Stedman, Mark Davies, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 2025
Does glycaemic control or renal function provide a better indicator for the service support required in type 1 diabetes?Adrian H Heald, Mike Stedman, Edward Jude, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 4, 2025
Consistency of the personalized glycated haemoglobin (pHbA1c) methodology over time in people with type 1 diabetes (T1D) using continuous glucose monitoringAdrian H Heald, Mike Stedman, Angela Paisley, et al.
Journal of Diabetes Science and Technology|May 17, 2021
People with Type 2 Diabetes Mellitus (T2DM) Self-Reported Views on Their Own Condition Management Reveal a High Level of Insight into the Challenges FacedMike Stedman, Rustam Rea, Mark Livingston, et al.
International Journal of Clinical Practice|August 10, 2021
Analysis of continuous glucose tracking data in people with type 1 diabetes after COVID-19 vaccination reveals unexpected link between immune and metabolic response, augmented by adjunctive oral medicationAdrian H Heald, Rustam Rea, Linda Horne, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Cardiovascular Endocrinology & Metabolism|September 25, 2024
The lifetime healthcare costs of female obesity: modeling of England data and the costs of current pharmacotherapyAdrian H Heald, Mike Stedman, John Warner-Levy, et al.
Lancet (London, England)|January 22, 2019
The costs of drug prescriptions for diabetes in the NHSMike Stedman, Mark Lunt, Mark Livingston, et al.
Primary Care Diabetes|July 16, 2025
The Influence of Local Service Configuration on All-Cause Mortality: An Age- and Sex-Standardised AnalysisMike Stedman, Mark Davies, Adam Robinson, et al.
Cardiovascular Endocrinology & Metabolism|June 26, 2023
First episode psychosis and weight gain a longitudinal perspective in Cheshire UK: a comparison between individuals with nonaffective versus affective psychosisAdrian H Heald, Mike Stedman, Chris Daly, et al.
The Journal of Clinical Endocrinology and Metabolism|August 12, 2025
Risk of death and adverse effects in patients on Liothyronine: a multi-source systematic review and meta-analysisSuhani Bahl, Peter N Taylor, Lakdasa D Premawardhana, et al.
Journal of Pharmaceutical Policy and Practice|December 21, 2023
Changes in prescribing of psychotropic vs some physical health medication in primary care through the COVID-19 pandemic in England: a national-level surveyUnaiza Waheed, Mike Stedman, Mark Davies, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 2025
Does glycaemic control or renal function provide a better indicator for the service support required in type 1 diabetes?Adrian H Heald, Mike Stedman, Edward Jude, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 4, 2025
Consistency of the personalized glycated haemoglobin (pHbA1c) methodology over time in people with type 1 diabetes (T1D) using continuous glucose monitoringAdrian H Heald, Mike Stedman, Angela Paisley, et al.
Journal of Diabetes Science and Technology|May 17, 2021
People with Type 2 Diabetes Mellitus (T2DM) Self-Reported Views on Their Own Condition Management Reveal a High Level of Insight into the Challenges FacedMike Stedman, Rustam Rea, Mark Livingston, et al.
International Journal of Clinical Practice|August 10, 2021
Analysis of continuous glucose tracking data in people with type 1 diabetes after COVID-19 vaccination reveals unexpected link between immune and metabolic response, augmented by adjunctive oral medicationAdrian H Heald, Rustam Rea, Linda Horne, et al.
Pageof 7